Menu
GeneBe

4-92590159-G-T

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_001510.4(GRID2):c.117G>T(p.Lys39Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,459,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000048 ( 0 hom. )

Consequence

GRID2
NM_001510.4 missense

Scores

2
5
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.47
Variant links:
Genes affected
GRID2 (HGNC:4576): (glutamate ionotropic receptor delta type subunit 2) The protein encoded by this gene is a member of the family of ionotropic glutamate receptors which are the predominant excitatory neurotransmitter receptors in the mammalian brain. The encoded protein is a multi-pass membrane protein that is expressed selectively in cerebellar Purkinje cells. A point mutation in the mouse ortholog, associated with the phenotype named 'lurcher', in the heterozygous state leads to ataxia resulting from selective, cell-autonomous apoptosis of cerebellar Purkinje cells during postnatal development. Mice homozygous for this mutation die shortly after birth from massive loss of mid- and hindbrain neurons during late embryogenesis. This protein also plays a role in synapse organization between parallel fibers and Purkinje cells. Alternate splicing results in multiple transcript variants encoding distinct isoforms. Mutations in this gene cause cerebellar ataxia in humans. [provided by RefSeq, Apr 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.41163415).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GRID2NM_001510.4 linkuse as main transcriptc.117G>T p.Lys39Asn missense_variant 2/16 ENST00000282020.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GRID2ENST00000282020.9 linkuse as main transcriptc.117G>T p.Lys39Asn missense_variant 2/161 NM_001510.4 P1O43424-1
GRID2ENST00000510992.5 linkuse as main transcriptc.117G>T p.Lys39Asn missense_variant 2/151 O43424-2
GRID2ENST00000505687.5 linkuse as main transcriptn.289G>T non_coding_transcript_exon_variant 2/61

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.0000120
AC:
3
AN:
250754
Hom.:
0
AF XY:
0.00000738
AC XY:
1
AN XY:
135480
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000984
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000479
AC:
7
AN:
1459970
Hom.:
0
Cov.:
29
AF XY:
0.00000275
AC XY:
2
AN XY:
726414
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000581
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 30, 2021The c.117G>T (p.K39N) alteration is located in exon 2 (coding exon 2) of the GRID2 gene. This alteration results from a G to T substitution at nucleotide position 117, causing the lysine (K) at amino acid position 39 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.79
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.26
Cadd
Benign
23
Dann
Uncertain
1.0
DEOGEN2
Benign
0.11
T;.
Eigen
Benign
-0.057
Eigen_PC
Benign
0.0012
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.96
D;D
M_CAP
Benign
0.079
D
MetaRNN
Benign
0.41
T;T
MetaSVM
Benign
-0.39
T
MutationAssessor
Benign
0.69
N;N
MutationTaster
Benign
0.97
D;N
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-0.60
N;N
REVEL
Uncertain
0.30
Sift
Benign
0.13
T;D
Sift4G
Uncertain
0.0040
D;D
Polyphen
0.95
P;.
Vest4
0.70
MutPred
0.45
Loss of ubiquitination at K39 (P = 0.0297);Loss of ubiquitination at K39 (P = 0.0297);
MVP
0.82
MPC
0.57
ClinPred
0.11
T
GERP RS
3.2
Varity_R
0.074
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs766470483; hg19: chr4-93511310; API